Screener
Discontinued — last reported Q1 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Harmony Biosciences Holdings, Inc.’s reported figures.
The source filing: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 8:16 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056720
FAQ
- What is Harmony Biosciences Holdings, Inc.'s net debt?
- Harmony Biosciences Holdings, Inc. (HRMY) reported net debt of -$424.79M in Q1 2026.
- How has Harmony Biosciences Holdings, Inc.'s net debt changed year-over-year?
- Harmony Biosciences Holdings, Inc.'s net debt decreased by 36.4% year-over-year, from -$311.53M to -$424.79M.
- What is the long-term trend for Harmony Biosciences Holdings, Inc.'s net debt?
- Over 5 years (2020 to 2025), Harmony Biosciences Holdings, Inc.'s net debt has grown at a 76.2% compound annual growth rate (CAGR), from -$34.38M to -$583.25M.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.
Ask your AI about Harmony Biosciences Holdings, Inc.'s net debt.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI

Claude